Maria Renna, MD
Geriatric Medicine · Wethersfield, CTNPI 1164750030
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 333 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,363, more than ten times the $227 reported in 2019. Among geriatric medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$956
- Lilly USA, LLC$812
- GSK$587
- AbbVie$432
- Novo Nordisk$379
- Pfizer$332
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,232100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $956 |
| Lilly USA, LLC | 46 | $812 |
| GSK | 41 | $587 |
| AbbVie(2 entities) | 33 | $432 |
| Novo Nordisk | 18 | $379 |
| Pfizer | 22 | $332 |
| Astellas Pharma US Inc | 10 | $248 |
| Boehringer Ingelheim | 11 | $243 |
| Exact Sciences | 10 | $235 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $225 |
| Viatris Specialty LLC | 10 | $179 |
| Abbott | 7 | $146 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| Lundbeck LLC | 5 | $103 |
| Corcept Therapeutics | 4 | $86 |
| Scilex Pharmaceuticals Inc. | 2 | $85 |
| Phathom Pharmaceuticals, Inc. | 2 | $80 |
| Novartis | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| E.r. Squibb & Sons, L.L.C. | 5 | $77 |
| Merck | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Seqirus USA Inc | 3 | $63 |
| Ardelyx, Inc. | 2 | $44 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Almatica Pharma LLC | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 2 | $39 |
| Baxter Healthcare | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Covis Pharma GmbH | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bayer | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
How this compares
$6,241 in reported general payments places this provider in the 95th percentile of 84 geriatric medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 178 | $221,704 |
| FarxigaDapagliflozin Propanediol | 130 | $132,730 |
| EliquisApixaban | 117 | $124,246 |
| JanuviaSitagliptin Phosphate | 94 | $113,348 |
| OzempicSemaglutide | 65 | $86,936 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $60,890 |
| XareltoRivaroxaban | 44 | $31,299 |
| InvokanaCanagliflozin | 13 | $28,786 |
| TrulicityDulaglutide | 11 | $25,913 |
| MyrbetriqMirabegron | 21 | $18,868 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $18,402 |
| EntrestoSacubitril/Valsartan | 21 | $18,002 |
| TrintellixVortioxetine Hydrobromide | 26 | $12,551 |
| TradjentaLinagliptin | 15 | $11,479 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $8,999 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $243 | $233,183193 claims |
| AstraZenecaFarxiga, Brilinta | $956 | $138,865144 claims |
| MerckJanuvia, Janumet | $69 | $131,750115 claims |
| PfizerEliquis | $332 | $124,246117 claims |
| Novo NordiskOzempic | $379 | $86,93665 claims |
| Johnson & JohnsonXarelto, Invokana, Concerta | $16 | $68,55868 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $587 | $67,29997 claims |
| Lilly USA, LLCTrulicity | $812 | $25,91311 claims |
| Astellas Pharma US IncMyrbetriq | $248 | $18,86821 claims |
| NovartisEntresto | $78 | $18,00221 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $113 | $12,55126 claims |
| AbbVieLinzess, Synthroid | $432 | $12,36468 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 84 geriatric medicine providers in Connecticut.
Other geriatric medicine in Wethersfield
- Margarita ReyesBristol$67K
- Susann VaranoNew Haven$25K
- Imran AliBridgeport$13K
- Sowmya KurtakotiHartford$9K
- Henry YaggiNew Haven$5K
- Marina BlagodatnyStratford$3K
- Jessica DacostaBrookfield$2K
- George KuchelFarmington$1K
- Mamta SinghWillimantic$965
- Edward BermanRidgefield$939
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.